慢性肾脏病：潜在分子机制——特刊概述。
Chronic Kidney Disease: Underlying Molecular Mechanisms-A Special Issue Overview.
机构信息
Associate Laboratory i4HB-Institute for Health and Bioeconomy, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
UCIBIO/REQUIMTE, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
出版信息
Int J Mol Sci. 2023 Aug 2;24(15):12363. doi: 10.3390/ijms241512363.
Abstract
Chronic kidney disease (CKD) is an epidemic health issue that requires global attention [...].
摘要
慢性肾脏病（CKD）是一个需要全球关注的流行健康问题[...]。
相似文献
1
Chronic Kidney Disease: Underlying Molecular Mechanisms-A Special Issue Overview.慢性肾脏病：潜在分子机制——特刊概述。
Int J Mol Sci. 2023 Aug 2;24(15):12363. doi: 10.3390/ijms241512363.
2
Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease".专刊编辑按语：“慢性肾脏病的共病”
Toxins (Basel). 2020 Jun 11;12(6):384. doi: 10.3390/toxins12060384.
3
Genomic biomarkers for chronic kidney disease.慢性肾脏病的基因组生物标志物。
Transl Res. 2012 Apr;159(4):290-302. doi: 10.1016/j.trsl.2012.01.020. Epub 2012 Feb 9.
4
Chronic kidney disease: a hidden epidemic.慢性肾脏病：一种隐匿的流行病。
Prilozi. 2008 Jul;29(1):5-9.
5
Understanding the role of genetic polymorphisms in chronic kidney disease.了解基因多态性在慢性肾脏病中的作用。
Pediatr Nephrol. 2008 Nov;23(11):1941-9. doi: 10.1007/s00467-008-0788-z. Epub 2008 Mar 27.
6
Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease.慢性肾脏病脂质代谢紊乱的分子机制。
Front Biosci (Landmark Ed). 2018 Jan 1;23(1):146-161. doi: 10.2741/4585.
7
Targeted screening of adult first-degree relatives for chronic kidney disease and its risk factors.对成年一级亲属进行慢性肾脏病及其危险因素的靶向筛查。
Nephron Clin Pract. 2010;116(2):c128-36. doi: 10.1159/000314662. Epub 2010 May 21.
8
Association between familial aggregation of chronic kidney disease and its incidence and progression.慢性肾脏病家族聚集与发病和进展的关系。
Sci Rep. 2023 Mar 29;13(1):5131. doi: 10.1038/s41598-023-32362-5.
9
Exploring the genetic basis of early-onset chronic kidney disease.探索早发性慢性肾脏病的遗传基础。
Nat Rev Nephrol. 2016 Mar;12(3):133-46. doi: 10.1038/nrneph.2015.205. Epub 2016 Jan 11.
10
Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease.内质网应激和自噬在急性肾损伤向慢性肾病转变中的作用
J Cell Physiol. 2023 Jan;238(1):82-93. doi: 10.1002/jcp.30918. Epub 2022 Nov 21.
引用本文的文献
1
TMAO Activates the NLRP3 Inflammasome, Disrupts Gut-Kidney Interaction, and Promotes Intestinal Inflammation.氧化三甲胺激活NLRP3炎性小体，破坏肠-肾相互作用，并促进肠道炎症。
Int J Mol Sci. 2025 Aug 1;26(15):7441. doi: 10.3390/ijms26157441.
2
Knowledge, Attitudes, and Practices Towards Exercise Therapy Among Patients with Stage 5 Chronic Kidney Disease on Regular Hemodialysis.接受定期血液透析的5期慢性肾病患者对运动疗法的知识、态度和实践
Int J Gen Med. 2024 Dec 11;17:5997-6008. doi: 10.2147/IJGM.S488141. eCollection 2024.
3
Phase angle is a useful predicting indicator for protein-energy wasting and cardiovascular risk among maintenance hemodialysis patients.相位角是维持性血液透析患者蛋白质能量消耗和心血管风险的有用预测指标。
Sci Rep. 2024 Nov 15;14(1):28151. doi: 10.1038/s41598-024-78957-4.
4
Pharmacological functions of salidroside in renal diseases: facts and perspectives.红景天苷在肾脏疾病中的药理作用：现状与展望。
Front Pharmacol. 2024 Jan 8;14:1309598. doi: 10.3389/fphar.2023.1309598. eCollection 2023.
5
Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?慢性肾脏病和终末期肾病患者肠道微生物群的临床视角：我们目前的进展如何？
Biomedicines. 2023 Sep 7;11(9):2480. doi: 10.3390/biomedicines11092480.
本文引用的文献
1
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases.从基础到临床：马利诺(bufagenin)在心血管和肾脏疾病中的作用新见解。
Int J Mol Sci. 2023 Jul 6;24(13):11186. doi: 10.3390/ijms241311186.
2
The Potential Modulatory Effects of Exercise on Skeletal Muscle Redox Status in Chronic Kidney Disease.运动对慢性肾脏病骨骼肌氧化还原状态的潜在调节作用。
Int J Mol Sci. 2023 Mar 23;24(7):6017. doi: 10.3390/ijms24076017.
3
Growth Hormone Improves Adipose Tissue Browning and Muscle Wasting in Mice with Chronic Kidney Disease-Associated Cachexia.生长激素可改善慢性肾脏病相关恶病质小鼠的脂肪组织褐变和肌肉减少症。
Int J Mol Sci. 2022 Dec 4;23(23):15310. doi: 10.3390/ijms232315310.
4
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.局灶节段性肾小球硬化症和微小病变性肾病的潜在尿液蛋白质组生物标志物。
Int J Mol Sci. 2022 Oct 20;23(20):12607. doi: 10.3390/ijms232012607.
5
Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease.细胞损伤的分子机制及毒性重金属在慢性肾脏病中的作用。
Int J Mol Sci. 2022 Sep 21;23(19):11105. doi: 10.3390/ijms231911105.
6
In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome.SH045 通过抑制 TRPC6 减轻代谢综合征新西兰肥胖（NZO）小鼠模型的肾脏纤维化。
Int J Mol Sci. 2022 Jun 20;23(12):6870. doi: 10.3390/ijms23126870.
7
Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation.短链脂肪酸在慢性肾脏病中的作用：聚焦于炎症和氧化应激调节。
Int J Mol Sci. 2022 May 11;23(10):5354. doi: 10.3390/ijms23105354.
8
Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline.在慢性肾脏病分期中的炎症生物标志物：升高的 TNFR2 水平伴随着肾功能下降。
Inflamm Res. 2022 Jun;71(5-6):591-602. doi: 10.1007/s00011-022-01574-2. Epub 2022 Apr 26.
9
Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?慢性肾脏病与肠道微生物群：它们在生命早期有何关联？
Int J Mol Sci. 2022 Apr 2;23(7):3954. doi: 10.3390/ijms23073954.
10
The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD.肿瘤坏死因子受体信号通路：将肾脏疾病的动物模型与人类慢性肾脏病联系起来。
Int J Mol Sci. 2022 Mar 18;23(6):3284. doi: 10.3390/ijms23063284.
Zotero 插件